Clinical Trial Update: Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a 1-day course of famciclovir to a 3-day course of valacyclovir in adults with recurrent genital herpes, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• Famvir (famciclovir)
• VALTREX (valacyclovir hydrochloride)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Genital Herpes | Phase 3 | Status: COMPLETED | Results posted: 2011-06-17